GlassScriptPhysician profile
Brian J Still
NPI 1154778652
$16,223.05
in general payments reported to CMS, 2019-2025
9 companies · $918 in 2025
The $918 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,673 · 2022: $12K · 2023: $199 · 2024: $780 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,418 · Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,417.60 |
| Food and Beverage | $478.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,200.00 | 2021-2022 | |
| Arthrex, INC. | $4,914.15 | 2022 | |
| Medwest Associates | $2,411.51 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $1,848.41 | 2022-2025 | |
| Stryker Corporation | $1,666.55 | 2021-2025 | Mako, Triathlon |
| Convatec INC. | $101.15 | 2023 | |
| Medical Device Business Services, INC. | $52.74 | 2025 | Na |
| Biocomposites INC | $15.85 | 2025 | Stimulan |
| Innovation Technologies INC | $12.69 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Still listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.